About: Strategies for the Prevention and Treatment of Iatrogenic Withdrawal from Opioids and Benzodiazepines in Critically Ill Neonates, Children and Adults: A Systematic Review of Clinical Studies

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Strategies for the Prevention and Treatment of Iatrogenic Withdrawal from Opioids and Benzodiazepines in Critically Ill Neonates, Children and Adults: A Systematic Review of Clinical Studies Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Strategies for the Prevention and Treatment of Iatrogenic Withdrawal from Opioids and Benzodiazepines in Critically Ill Neonates, Children and Adults: A Systematic Review of Clinical Studies
Creator	Mehta, Sangeeta Burry, Lisa David, · Dagenais, Maryse Duceppe, Marc-Alexandre Frenette, Anne Gélinas, Céline Lavoie, Annie Perreault, Marc Rico, Philippe Sneyers, Barbara Williamson, R
Source	PMC
abstract	BACKGROUND: Critically ill patients are at high risk of iatrogenic withdrawal syndrome (IWS), due to exposure to high doses or prolonged periods of opioids and benzodiazepines. PURPOSE: To examine pharmacological management strategies designed to prevent and/or treat IWS from opioids and/or benzodiazepines in critically ill neonates, children and adults. METHODS: We included non-randomised studies of interventions (NRSI) and randomised controlled trials (RCTs), reporting on interventions to prevent or manage IWS in critically ill neonatal, paediatric and adult patients. Database searching included: PubMed, CINAHL, Embase, Cochrane databases, TRIP, CMA Infobase and NICE evidence. Additional grey literature was examined. Study selection and data extraction were performed in duplicate. Data collected included: population, definition of opioid, benzodiazepine or mixed IWS, its assessment and management (drug or strategy, route of administration, dosage and titration), previous drug exposures and outcomes measures. Methodological quality assessment was performed by two independent reviewers using the Cochrane risk of bias tool for RCTs and the ROBINS-I tool for NRSI. A qualitative synthesis of the results is provided. For the subset of studies evaluating multifaceted protocolised care, we meta-analysed results for 4 outcomes and examined the quality of evidence using GRADE post hoc. RESULTS: Thirteen studies were eligible, including 10 NRSI and 3 RCTs; 11 of these included neonatal and paediatric patients exclusively. Eight studies evaluated multifaceted protocolised interventions, while 5 evaluated individual components of IWS management (e.g. clonidine or methadone at varying dosages, routes of administration and duration of tapering). IWS was measured using an appropriate tool in 6 studies. Ten studies reported upon occurrence of IWS, showing significant reductions (n = 4) or no differences (n = 6). Interventions failed to impact duration of mechanical ventilation, ICU length of stay, and adverse effects. Impact on opioid and/or benzodiazepine total doses and duration showed no differences in 4 studies, while 3 showed opioid and benzodiazepine cumulative doses were significantly reduced by 20–35% and 32–66%, and treatment durations by 1.5–11 and 19 days, respectively. Variable effects on intervention drug exposures were found. Weaning durations were reduced by 6–12 days (n = 4) for opioids and/or methadone and by 13 days (n = 1) for benzodiazepines. In contrast, two studies using interventions centred on transition to enteral routes or longer tapering durations found significant increases in intervention drug exposures. Interventions had overall non-significant effects on additional drug requirements (except for one study). Included studies were at high risk of bias, relating to selection, detection and reporting bias. CONCLUSION: Interventions for IWS management fail to impact duration of mechanical ventilation or ICU length of stay, while effect on occurrence of IWS and drug exposures is inconsistent. Heterogeneity in the interventions used and methodological issues, including inappropriate and/or subjective identification of IWS and bias due to study design, limited the conclusions. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s40265-020-01338-4) contains supplementary material, which is available to authorized users.
has issue date	2020-06-26(xsd:dateTime)
bibo:doi	10.1007/s40265-020-01338-4
has license	no-cc
sha1sum (hex)	0aa141040539da636bc0ba86bb40920d9721aa49
schema:url	https://doi.org/10.1007/s40265-020-01338-4
resource representing a document's title	Strategies for the Prevention and Treatment of Iatrogenic Withdrawal from Opioids and Benzodiazepines in Critically Ill Neonates, Children and Adults: A Systematic Review of Clinical Studies
has PubMed Central identifier	PMC7317263
schema:publication	Drugs
resource representing a document's body	covid:0aa141040539da636bc0ba86bb40920d9721aa49#body_text
is schema:about of	named entity 'cumulative' named entity 'benzodiazepines' named entity 'stay' named entity 'studies' named entity 'limited' named entity 'effects' named entity 'relating' named entity 'measured' named entity 'databases' named entity 'measures' named entity 'patients' named entity 'studies' named entity 'evidence' named entity 'withdrawal syndrome' named entity 'Variable' named entity 'Iatrogenic' named entity 'Critically' named entity 'ROUTES' named entity 'RANDOMISED CONTROLLED TRIALS' named entity 'DUPLICATE' named entity 'CUMULATIVE' named entity 'DATA COLLECTED' named entity 'INCREASES' named entity 'RISK OF BIAS' named entity 'CLONIDINE' named entity 'DETECTION' named entity 'IDENTIFICATION' named entity 'SELECTION' named entity 'ADVERSE EFFECTS' named entity 'PATIENTS' named entity 'HIGH' named entity 'INAPPROPRIATE' named entity 'DAYS' covid:arg/0aa141040539da636bc0ba86bb40920d9721aa49 named entity 'studies' named entity 'route' named entity 'routes' named entity 'durations' named entity 'studies' named entity 'evaluating' named entity 'treat' named entity 'individual' named entity 'RCTs' named entity 'benzodiazepine' named entity 'selection' named entity 'total' named entity 'Weaning' named entity 'post hoc' named entity 'duration' named entity 'subjective' named entity 'subset' named entity 'prevent' named entity 'Thirteen' named entity 'tool' named entity 'failed' named entity 'periods' named entity 'clonidine' named entity 'durations' named entity 'administration' named entity 'opioid' named entity 'Database' named entity 'iatrogenic' named entity 'quality assessment' named entity 'benzodiazepines' named entity 'methodological issues' named entity 'opioids' named entity 'Weaning' named entity 'opioid' named entity 'pharmacological' named entity 'RCTs' named entity 'ICU' named entity 'neonatal'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software